Aesculus/Quercus comp. Suppositorien

Valsts: Šveice

Valoda: vācu

Klimata pārmaiņas: Swissmedic (Swiss Agency for Therapeutic Products)

Aktīvā sastāvdaļa:

aesculus hippocastanum e semine rec. ferm 34c TM (HAB 34c), borago officinalis e foliis ferm 34b TM (HAB 34b), hamamelis virginiana e foliis ferm 33d TM (HAB 33d), silybum marianum e fructibus sicc. ferm 36 TM (HAB 36), quercus robur/petraea e cortice decoctum TM (HAB 23a)

Pieejams no:

WALA Schweiz AG

SNN (starptautisko nepatentēto nosaukumu):

aesculus hippocastanum e semine rec. ferm 34c TM (HAB 34c), borago officinalis e foliis ferm 34b TM (HAB 34b), hamamelis virginiana e foliis ferm 33d TM (HAB 33d), silybum marianum e fructibus sicc. ferm 36 TM (HAB 36), quercus robur/petraea e cortice decoctum TM (HAB 23a)

Zāļu forma:

Suppositorien

Kompozīcija:

extractum spissum 20 mg ex aesculus hippocastanum e semine ferm 34c TM (HAB 34c) 10 mg, borago officinalis e foliis ferm 34b TM (HAB 34b) 10 mg, hamamelis virginiana e foliis ferm 33d TM (HAB 33d) 10 mg et silybum marianum e fructibus sicc. ferm 36 TM (HAB 36) 10 mg, extractum spissum 20 mg ex quercus robur/petraea e cortice decoctum TM (HAB 23a) 200 mg, adeps solidus, mel, pro suppositorio 2 g.

Klase:

D

Ārstniecības grupa:

Anthroposophische Arzneimittel

Ārstniecības joma:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

Autorizācija statuss:

zugelassen

Autorizācija datums:

2012-04-12